remacemide has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schachter, SC; Tarsy, D | 1 |
| Adler, C; Alderfer, V; Baker, D; Bardram, K; Bateman-Rodriguez, D; Belden, J; Blasucci, L; Brewer, M; Broshjeit, S; Brown, D; Carrion, A; Casaceli, C; Cha, JH; Chase, T; Colcher, A; Comella, C; Cooper, J; Cox, C; Craun, AM; Davies, R; Day, D; Deleo, A; Dilllon, S; Dingmann, C; Dobson, J; Elmer, L; Factor, S; Fahn, S; Feigin, A; Florack, M; Ford, B; Frey, J; Friedlander, J; Gauger, L; Gray, P; Greenamyre, JT; Grimes, D; Hall, J; Hammerstad, J; Harrison, M; Hauser, R; Hodgeman, K; Holdich, T; Janko, K; Jennings, D; Johnston, L; Kayson, E; Kennedy, L; Lafontaine, AL; Lang, A; Lannon, M; Laroia, N; Leventhal, C; Lew, MF; Lewitt, P; Lloyd, M; Locke, B; Marek, K; Martin, W; Matthews, M; Mazurkiewicz, J; McCree, L; McDermott, J; McDermott, M; McGuire, D; Mistura, K; Miyasaki, J; Newman, S; Nobel, R; Orme, C; Pahwa, R; Panniset, M; Pantella, C; Pearson, N; Penney, J; Read, B; Rexo, L; Rodnitzky, R; Rost, E; Rothenburgh, K; Ruzicka, D; Ryan, P; Schuman, S; Schwid, S; Seeberger, L; Shoulson, I; Shulman, L; Siderowf, A; Siemers, E; Stacy, M; Stone, C; Suchowersky, O; Sulimowicz, K; Tariot, P; Tarsy, D; Tennis, M; Tetrud, J; Watts, A; Wiener, W; Wratni, E | 1 |
1 review(s) available for remacemide and Parkinson Disease
| Article | Year |
|---|---|
Remacemide: current status and clinical applications.
Topics: Acetamides; Animals; Anticonvulsants; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Huntington Disease; Intraoperative Complications; Neuroprotective Agents; Parkinson Disease; Phenethylamines; Receptors, N-Methyl-D-Aspartate | 2000 |
3 trial(s) available for remacemide and Parkinson Disease
| Article | Year |
|---|---|
A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD. Parkinson Study Group.
Topics: Acetamides; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neurologic Examination; Neuroprotective Agents; Parkinson Disease; Severity of Illness Index; Treatment Outcome | 2000 |
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
Topics: Acetamides; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Parkinson Disease; Patient Compliance; Receptors, Glutamate | 2001 |
Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease.
Topics: Acetamides; Activities of Daily Living; Anticonvulsants; Dyskinesias; Humans; Informed Consent; Levodopa; Medical Records; Mental Status Schedule; Middle Aged; Motor Activity; Neuroprotective Agents; Parkinson Disease; Pilot Projects; Placebos; Reproducibility of Results; Treatment Outcome | 2001 |